Komiyama A, Kamo I, Furukawa S, Akazawa S, Hirayama K, Satoyoshi E
Department of Neurology, Chiba University School of Medicine, Japan.
J Neurol. 1988 Mar;235(4):207-13. doi: 10.1007/BF00314348.
Antibodies against phosphate-buffered-saline extracts (SE) of non-acetylcholine receptor (AChR) skeletal muscle antigens were found in patients with myasthenia gravis (MG). The antigenicity of SE was distributed in three fractions with molecular masses of over 200 kDa, 90-150 kDa and 7-14 kDa on gel filtration. These fractions shared common antigenicities. Further analysis of 90-150 kDa fractions on sodium dodecyl sulphate polyacrylamide gel electrophoresis showed five major bands, ranging from 105 kDa to 275 kDa. The antibodies against SE were detected in 52% (58/112) of the MG patients; incidence and titres were higher in the thymoma group (n = 21; 90% and 0.872 respectively) than in the non-thymoma group (n = 91; 43% and 0.200, P less than 0.001). In patients without a thymoma, these antibodies were frequently observed in late-onset disease and the severe generalized form (P less than 0.01). In 4 of 7 ocular MG patients without anti-AChR antibodies, low but appreciable levels of anti-SE antibodies were found. In 73% (11/15) of generalized MG patients treated with prednisolone and thymectomy, anti-SE antibody titres changed in association with those of anti-AChR antibodies and with the clinical course. Both antibody titres increased synchronously in patients who developed crises.
在重症肌无力(MG)患者中发现了针对非乙酰胆碱受体(AChR)骨骼肌抗原的磷酸盐缓冲盐水提取物(SE)的抗体。凝胶过滤显示,SE的抗原性分布在分子量超过200 kDa、90 - 150 kDa和7 - 14 kDa的三个组分中。这些组分具有共同的抗原性。对90 - 150 kDa组分进行十二烷基硫酸钠聚丙烯酰胺凝胶电泳进一步分析,显示出五条主要条带,分子量范围为105 kDa至275 kDa。52%(58/112)的MG患者检测到抗SE抗体;胸腺瘤组(n = 21;分别为90%和0.872)的发生率和滴度高于非胸腺瘤组(n = 91;43%和0.200,P < 0.001)。在无胸腺瘤的患者中,这些抗体在晚发型疾病和重度全身型中常见(P < 0.01)。在7例无抗AChR抗体的眼肌型MG患者中,有4例发现抗SE抗体水平较低但仍可检测到。在15例接受泼尼松龙和胸腺切除术治疗的全身型MG患者中,73%(11/15)的抗SE抗体滴度与抗AChR抗体滴度及临床病程相关。在发生危象的患者中,两种抗体滴度同步升高。